Dabigatran EMA - product-specific guide [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2019-02-13 22:59  – Posting: # 19910
Views: 703

Hi nobody,


» http://www.sciencemag.org/careers/2012/02/ive-got-your-impact-factor-right-here

Thanks for this link.
"And the Journal of Negative Results in Homeopathy is the entire field of homeopathy." :-D:-D:-D:-D:-D:-D:-D:-D:-D:-D:-D

Best day ever.

if (3) 4

x=c("Foo", "Bar")
b=data.frame(x)
typeof(b[,1]) ##aha, integer?
b[,1]+1 ##then let me add 1


Best regards,
ElMaestro

“(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures.” New York Times (ed.), June 9, 2018.

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,404 posts in 4,122 threads, 1,323 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time (Europe/Vienna): 18:59 CEST

No rational argument will have a rational effect on a man
who does not want to adopt a rational attitude.    Karl R. Popper

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5